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Abstract The action of bradykinin was studied in rat-1
fibroblasts stably expressing K1b-adrenoceptors. It was observed
that bradykinin and kallidin markedly increase cytosol calcium
concentration, but that the B1 agonist, des-Arg9-bradykinin,
only mimicked this effect to a minimal extent. Antagonists,
selective for the B2 subtype, such as Hoe 140, blocked this effect
of bradykinin and kallidin. Similarly, bradykinin and kallidin
stimulated the production of inositol phosphates and B2
antagonists blocked their actions.
The possibility that bradykinin could modulate K1b-adrenocep-
tors was studied. It was observed that bradykinin and kallidin
increased K1b-adrenoceptor phosphorylation and that such effect
was also blocked by Hoe 140. Interestingly, the ability of
norepinephrine to increase intracellular calcium concentration
was not altered by pretreatment of the cells with bradykinin, i.e.
bradykinin induced K1b-adrenoceptor phosphorylation but this
did not lead to receptor desensitization.
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1. Introduction
Protein phosphorylation is a well-known cardinal event in
the regulation of cellular functioning. The properties (i.e. ac-
tivity, intracellular location, etc.) of many proteins, such as
those involved in the control of metabolism or in signal trans-
duction are critically in£uenced by phosphorylation. Among
those proteins involved in signal transduction, G protein-
coupled receptors are important targets of protein kinases
[1,2].
K1b-Adrenoceptors are members of the seven transmem-
brane domains G protein-coupled families of receptors that
modulate phosphoinositide turnover and calcium signalling
[3^5]. The function of these receptors seems to be regulated
by phosphorylation/dephosphorylation reactions. Agonist
stimulation induces homologous desensitization of these re-
ceptors, which is associated to receptor phosphorylation [6^
11]; there is evidence that kinases speci¢c for the agonist-oc-
cupied G protein-coupled receptors, such as GRK2 and
GRK3 participate in this desensitization [10]. In addition,
activation of non-adrenergic receptors can also lead to K1b-
adrenoceptor (heterologous) desensitization [7,11^13]. We
have previously shown that endothelin through ETA receptors
induces the phosphorylation and desensitization of K1b-adre-
noceptors in rat-1 ¢broblasts; protein kinase C and putative
protein tyrosine kinase(s) seem to participate in this type of
desensitization. However, the information that exists about
this process is very limited.
Bradykinin is a nonapeptide local mediator, prototypic
member of the kinins. This peptide mediates important phys-
iological functions such as smooth muscle contraction, cell
growth or ion transport in a large variety of cells [14,15]. It
also participates in pathophysiological processes such as pain
sensation, hypotension and edema formation [14]. The actions
of bradykinin are mediated through two types of receptors,
B1 and B2; most of its physiological actions involve the B2
subtype [14,15]. In the present paper we show that activation
of bradykinin B2 receptors induces phosphorylation of K1b-
adrenoceptors.
2. Materials and methods
Bradykinin, kallidin (Lys-bradykinin), des-Arg9-bradykinin, NK-
adamantaneacetyl-D-Arg-[Hyp3,Thi5;8,D-Phe]-bradykinin, des-Arg9-
[Leu8]-bradykinin, (3)-norepinephrine, endothelin, protease inhibitors
and all other reagents, unless stated otherwise, were obtained from
Sigma Chemical Co. Hoe 140 and des-Arg10-Hoe 140 were from Re-
search Biochemicals International. Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM), fetal bovine serum, trypsin, antibiotics and other
reagents used for cell culture were from Gibco BRL. Myo-[2-
3H]inositol (22.9 Ci/mmol) and [32P]Pi (8500^9120 Ci/mmol) were
from New England Nuclear. Sepharose-coupled protein A was from
Upstate Biotechnology and Fura-2/AM was from Molecular Probes.
Rat-1 ¢broblasts transfected with the hamster K1b-adrenoceptor
[16], were generously provided to us by Drs. R.J. Lefkowitz, M.G.
Caron and L. Allen (Duke University). The cells were cultured in
glutamine-containing high glucose DMEM supplemented with 10%
fetal bovine serum, 300 Wg/ml of the neomycin analog, G-418 sulfate,
100 Wg/ml streptomycin, 100 U/ml penicillin and 0.25 Wg/ml ampho-
tericin B at 37‡C under a 95% air/5% CO2 atmosphere, as described
previously [11,17]. In the present experiments, cells at con£uence were
serum-deprived in unsupplemented DMEM for 24 h.
Receptor phosphorylation studies were performed as described in
detail [11]. In brief, cells were maintained in phosphate-free DMEM
during 1 h and then incubated in 3 ml of the same medium containing
[32P]Pi (0.05 mCi/ml) for 3 h at 37‡C. Labeled cells were stimulated as
indicated, then they were washed twice with ice-cold phosphate bu¡-
ered saline and solubilized with 1 ml of ice-cold solubilization bu¡er
[11]. The extracts were centrifuged and the supernatants transferred to
tubes containing anti-K1b-adrenoceptor antiserum and sepharose-
coupled protein A and immunoprecipitated as described [11]. The
amount of phosphorylated receptor was determined by PhosphorIm-
ager analysis. At least three independent experiments were performed
for each treatment. Data were analyzed and plotted using commercial
software (Prism 2.01, GraphPad Software).
Intracellular calcium concentration ([Ca2]i) was quanti¢ed as de-
scribed [17]. In brief, ¢broblasts were incubated overnight in DMEM
without serum and antibiotics. Cells were loaded with Fura-2/AM in
Krebs-Ringer-HEPES containing 0.05% bovine serum albumin, pH
7.4 for 1 h at 37‡C. Fluorescence measurements were performed
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with excitation monochromators set at 340 and 380 nm, with a chop-
per interval of 0.5 s, and the emission monochromator set at 510 nm.
The [Ca2]i was calculated according to Grynkiewicz et al. [18] using
the software provided by AMINCO-Bowman; traces were directly
exported to the graphs. Ki values were calculated according to Cheng
and Pruso¡ [19].
Production of [3H]inositol phosphates was performed essentially as
described [17]. Brie£y, cells were labeled with [3H]inositol (6 WCi/ml)
for 18^24 h in 1 ml of inositol-free DMEM containing 1% fetal bovine
serum. Cells were washed twice with Krebs-Ringer-HEPES bu¡er
containing 1.3 mM CaCl2 and preincubated for 20 min in bu¡er
containing 10 mM LiCl. Incubations with the agents to be tested
were for 15 min and were terminated by the addition of perchloric
acid. [3H]Inositol phosphates were separated by Dowex AG1-X8
chromatography [20]. Total [3H]inositol phosphate production is pre-
sented.
3. Results and discussion
Previous studies have shown that there is clonal variation in
the presence of endogenous bradykinin receptors in rat-1 ¢-
broblasts. In some clones, a small number of receptors have
been found [21] whereas in others no binding sites or func-
tional responses have been detected [22]. In addition, it has
been reported that the expression of some genes, such as the
ras oncogene, markedly increases the expression of bradykinin
receptors in these cells [21]. Therefore, we investigated the
presence of endogenous bradykinin receptors in rat-1 ¢bro-
blasts stably expressing K1b-adrenoceptors, by studying two
functional responses, i.e. the ability of bradykinin to increase
[Ca2]i and to induce the production of [3H]inositol phos-
phates.
It can be observed in Fig. 1 that bradykinin and kallidin
increased in concentration-dependent fashion [Ca2]i in these
cells ; both natural agonists had similar potency (EC50V50
nM) and equal e⁄cacy. In contrast, the B1-selective agonist,
des-Arg9-bradykinin only induced a marginal increase in
[Ca2]i (Fig. 1, upper panel). The e¡ect of 100 nM bradykinin
on this parameter was inhibited in concentration-dependent
fashion by the B2 antagonists, Hoe 140 and NK-adamanta-
neacetyl-D-Arg-[Hyp3,Thi5;8,D-Phe7]-bradykinin; the former
was consistently more potent than the latter (Ki values 3.5
nM and 18 nM, respectively) (Fig. 1, middle panel). Des-
Arg10-Hoe 140, a B1-selective antagonist, only partially inhib-
ited the e¡ect of bradykinin at the highest concentration
tested whereas des-Arg9-[Leu8]-bradykinin, another B1-selec-
tive antagonist, was completely ine¡ective in the range of
concentrations tested (Fig. 1, middle panel). The e¡ect of
kallidin on [Ca2]i was also completely blocked by Hoe 140
(Fig. 1, lower panel). The antagonists by themselves did not
modify basal [Ca2]i. The data clearly indicated that bradyki-
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Fig. 1. E¡ect of bradykinin agonists and antagonists on intracellular
free calcium concentration. Upper panel: cells were incubated in the
presence of di¡erent concentrations of bradykinin (closed circles),
kallidin (closed triangles) or des-Arg9-bradykinin (open circles).
Data are the changes in intracellular calcium in response to the
agents; basal [Ca2]i was 128 þ 19 nM. Plotted are the means
þ S.E.M. of 3^7 experiments using di¡erent cell cultures. Middle
panel: cells were incubated for 1 min in the presence of di¡erent
concentrations of the antagonists: Hoe 140 (solid circles), NK-ada-
mantaneacetyl-D-Arg-[Hyp3,Thi5;8,D-Phe]-bradykinin (solid triangles),
des-Arg10-Hoe 140 (open circles) or des-Arg9-[Leu8]-bradykinin
(open triangles); after this preincubation 100 nM bradykinin (BK)
was added. Data are the changes in intracellular calcium in response
to bradykinin as compared to the e¡ect of that of bradykinin alone
(100%). Plotted are the means þ S.E.M. of 3^4 experiments using
di¡erent cell cultures. Lower panel: cells were preincubated for
1 min in the absence of antagonist (dashed columns) or presence of
1 WM Hoe 140 and challenged with 100 nM bradykinin (left group)
or 100 nM kallidin (right group). Data are the changes in intracellu-
lar calcium in response to the agents; basal [Ca2]i was 101 þ 15
nM. Plotted are the means þ S.E.M. of 3 experiments using di¡erent
cells cultures.
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nin receptors of the B2 subtype were present in rat-1 ¢bro-
blasts stably expressing K1b-adrenoceptors.
The ability of bradykinin to increase [Ca2]i was observed
in bu¡er containing 2.5 mM EGTA (data not shown) which
indicated that calcium mobilization from intracellular stores
was involved. Therefore, the ability of these agents to stimu-
late the production of [3H]inositol phosphates was tested.
Bradykinin and kallidin stimulated the production of
[3H]inositol phosphates and their e¡ects were completely
blocked by Hoe 140 (Fig. 2). The data con¢rmed that these
cells endogenously express B2 bradykinin receptors and fur-
ther indicated that these receptors are coupled to phospho-
inositide turnover and calcium mobilization, as observed in
many other models [14,15,22]. It should be mentioned that
the e¡ect of bradykinin on this parameter is relatively small
(40^50% over basal), since in the same experiments 10 nM
endothelin was able to increase [3H]inositol phosphate pro-
duction up to 2.5-fold (data not shown).
We next examined the possibility that activation of B2 bra-
dykinin receptors may lead to K1b-adrenoceptor phosphoryla-
tion. As shown in Fig. 3, bradykinin induced phosphorylation
of the adrenergic receptor in a concentration-dependent fash-
ion. The maximum increase was V40^50% over basal and it
was observed at concentrations between 1 and 3 WM, with an
EC50 of V500 nM. Kallidin was also able to induce K1b-
adrenoceptor phosphorylation and the e¡ect of both natural
agonists, bradykinin and kallidin, was completely blocked by
the B2 antagonist, Hoe 140 (Fig. 4). The antagonist by itself
was without e¡ect on the basal receptor labeling. These data
clearly indicate that the same B2 receptors mediate both ac-
tions of bradykinin, increase in [Ca2]i and induction of adre-
noceptor phosphorylation. The 10-fold di¡erence in EC50 val-
ues observed for these e¡ects of the peptide is not surprising.
This di¡erence suggests that bigger receptor occupation than
calcium mobilization is required to induce receptor phospho-
rylation, or expressed in other words, that a small generation
of IP3 could be su⁄cient to increase [Ca2]i but that other
factors are important to induce receptor phosphorylation.
We next studied the functional consequences of bradykinin-
induced adrenoceptor phosphorylation by examining the ef-
fect of norepinephrine on [Ca2]i. As shown in Fig. 5, 10 WM
norepinephrine induced a marked increase in [Ca2]i. When
cells were pretreated with 1 WM bradykinin the e¡ect of nor-
epinephrine was not a¡ected. Under the same conditions, 10
nM endothelin markedly decreased the e¡ect of norepinephr-
ine on this parameter (Fig. 5). It should be mentioned that
even lower concentrations of endothelin that induce a much
smaller e¡ect on [Ca2]i were able to diminish clearly the
e¡ect of norepinephrine (data not shown, please see [11]). In
addition, we studied if the actions of smaller concentrations of
norepinephrine were a¡ected by the action of the peptide
without observing any clear e¡ect (data not shown). The pos-
sibility that a longer exposure to bradykinin (up to 15 min)
could be required to a¡ect the action of the catecholamine
was tested without success (data not shown). It was clear,
therefore, that in spite of inducing receptor phosphorylation,
bradykinin did not lead to K1b-adrenoceptor desensitization in
rat-1 ¢broblasts.
Our results are consistent with data previously published in
DDT1 MF-2 cells in which it was observed that bradykinin
induced a small e¡ect on phospholipid labeling and also phos-
phorylation of K1-adrenoceptors [7]. However, some marginal
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Fig. 3. E¡ect of bradykinin on K1b-adrenoceptor phosphorylation.
Cells were incubated in the absence (basal) or presence of di¡erent
concentrations of bradykinin. Plotted are the means þ S.E.M. of 4^5
experiments using di¡erent cell cultures. In the lower panel a repre-
sentative autoradiograph is presented.
Fig. 2. E¡ect of bradykinin agonists and antagonists on [3H]inositol
phosphate production. Cells were incubated in the absence or pres-
ence (solid columns) of 1 WM Hoe 140 with no other agent (left
group), 100 nM bradykinin (middle group) or 100 nM kallidin
(right group). Plotted are the means þ S.E.M. of 5^7 experiments us-
ing di¡erent cell cultures.
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desensitization of the K1b-adrenergic action was detected in
those experiments [7]. It is possible, therefore, that the
strength of the signal generated by bradykinin could be in-
su⁄cient to desensitize K1b-adrenergic action in rat-1 ¢bro-
blasts but that in other cells where K1b-adrenoceptors and
B2 bradykinin receptors are coexpressed, such interaction
may have functional consequences. Nevertheless, it is clear
that receptor phosphorylation does not necessarily indicate
receptor desensitization. In fact, it has been observed that
overexpression of GRK5 and GRK6 markedly increases
K1b-adrenoceptor phosphorylation but does not a¡ect the re-
ceptor-mediated responses [10]. Additionally, our data clearly
indicate that agonist-induced calcium mobilization is not suf-
¢cient to induce desensitization of K1b-adrenoceptors. Activa-
tion of protein kinase C and putative protein tyrosine kin-
ase(s) seem to mediate K1b-adrenoceptor phosphorylation
induced by heterologous stimuli [11]. Interestingly, bradykinin
is able to activate protein kinase C [23] and there is also
evidence that the kinin induces protein tyrosine phosphoryla-
tion [24].
In summary, our data indicate that bradykinin B2 receptors
are endogenously expressed in rat-1 ¢broblasts and that acti-
vation of such receptors induce increases in [Ca2]i, phospho-
inositide turnover and leads to K1b-adrenoceptor phosphoryl-
ation.
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